Considering Progestin-Only Injectables Where HIV Risk Is High: Counseling Tips

Considering Progestin-Only Injectables Where HIV Risk Is High: Counseling Tips This job aid is part of the Family Planning Global Handbook. It provides counseling tips for service providers working with clients who are at risk for HIV.       Published:...

Depo-Provera Reminder Sticker for Providers [English]

Depo-Provera Reminder Sticker for Providers [English] Sticker to remind providers to counsel women on the potential increased risk of HIV acquisition. This tool was developed for a pilot study with providers in Tanzania.       Published: 2018 Source:...

An Overview of Subcutaneous DMPA

An Overview of Subcutaneous DMPA Subcutaneous DMPA, or DMPA-SC,* is an innovative product that makes injections simpler. Because DMPA-SC is easy to use, any trained person can administer it, including community health workers, pharmacists, and even women themselves....

Hormonal Contraception and Potential HIV Risks: Frequently Asked Questions and Counselling Messages [English]

Hormonal Contraception and Potential HIV Risks: Frequently Asked Questions and Counselling Messages [English] Answers frequently asked questions that providers may have about hormonal contraception and risk of HIV acquisition and provides some basic messages to...

Injectable Birth Control Increases HIV Risk by 40%

Injectable Birth Control Increases HIV Risk by 40% This article summarizes evidence from the Hapgood study concluding that women using the injectable progestin contraceptive depot medroxyprogesterone acetate, or DMPA, may face a substantially elevated risk for HIV...